Pharma Joins Forces With WHO, Global Governments In Unprecedented Effort To Control Neglected Tropical Diseases
This article was originally published in PharmAsia News
Executive Summary
Big Pharma join hands with WHO, global governments and foundations in unprecedented effort to wipe out neglected tropical diseases.
You may also be interested in...
DNDi Mulls Expansion Of India Site; Set To Team With More Pharma On The Heels Of Sanofi Deal - BIO Conference
WASHINGTON - Six years after establishing its India office, Geneva-based Drugs for Neglected Diseases Initiative (DNDi) is planning to expand its presence to cater to the drug development needs of the Indian population as well as neighboring countries like Bangladesh and Sri Lanka
Big Pharma More Willing To Cooperate On Neglected Disease Research But Funding Models Still Unclear
HONG KONG - Debate over how best to fund research and development of neglected diseases may be reshaped by changing patterns of cooperation among Big Pharma and non-industry groups
Southeast Asian Regulators Ramp Up Anti-Corruption, Bribery Enforcement Ahead of ASEAN Pact
Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.